Manufacturer:

Immunogen

Name:

ELAHERE

HCPCS Code Descriptor:

Injection, mirvetuximab soravtansine-gynx, 1 mg

Category:

C Code

HCPCS:

C9146

NDC(s):

72903-0853-01,

Primary Type:

Oncology

Route of Administration:

Intravenous

About:

ELAHERE is an Oncology drug manufactured by Immunogen and administered via the Intravenous route of administration. The C Code: C9146 is aligned to the drug ELAHERE.

Patient Assistance: